Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -695.18 | N/A |
PEG Ratio (TTM) | -6.95 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 0.22 | N/A |
P/FCF Ratio (TTM) | -11,205.58 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.03% | N/A |
ROE (TTM) | -0.06% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -129.01% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -129.10% | N/A | N/A |
Cash Flow | -26.17% | N/A | N/A |
Health (44%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.81 | N/A |
Quick Ratio (TTM) | 8.81 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 1 | N/A |
Altman Z-Score | 15.23 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |